Abstract
Oligomerization of G-protein-coupled receptors (GPCRs) is emerging as a mechanism for regulation and functional modification, although it has been studied most extensively for Family A receptors. Family B receptors have clear structural differences from Family A. In this paper, we have systematically evaluated GPCRs that are capable of association with the prototypic Family B secretin receptor. All of the receptor constructs were shown to traffic normally to the plasma membrane. We utilized receptor bioluminescence resonance energy transfer (BRET) to determine the presence of constitutive and ligand-dependent receptor association. Extensive intra-family and no cross-family association was observed. Of the nine Family B receptors studied, all constitutively yielded a significant BRET signal with the secretin receptor, except for the calcitonin receptor. Each of the associating hetero-oligomeric receptor pairs generated a BRET signal of similar intensity, less than that of homo-oligomeric secretin receptors. BRET signals from some receptor pairs were reduced by ligand occupation, but none were increased by this treatment. Thus, Family B GPCR oligomerization occurs, with many structurally related members associating with each other. The specific functional implications of this need to be further evaluated.
Similar content being viewed by others
Abbreviations
- BRET:
-
bioluminescence resonance energy transfer
- CLR:
-
calcitonin receptor-like receptor
- CTR:
-
calcitonin receptor
- FRET:
-
fluorescence resonance energy transfer
- GHRHR:
-
growth hormone releasing hormone receptor
- GLP1R:
-
type 1 glucagon-like peptide receptor
- GLP2R:
-
type 2 glucagon-like peptide receptor
- PTH1R:
-
type 1 parathyroid hormone receptor
- PTH2R:
-
type 2 parathyroid hormone receptor
- Rlu:
-
Renilla luciferase
- SecR:
-
secretin receptor
- VIP:
-
vasoactive intestinal polypeptide
- VPAC1R:
-
type 1 vasoactive intestinal polypeptide receptor
- VPAC2R:
-
type 2 vasoactive intestinal polypeptide receptor
- YFP:
-
yellow fluorescent protein
References
Cheng, Z. J., Harikumar, K. G., Holicky, E. L., & Miller, L. J. (2003). Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth. Journal of Biological Chemistry, 278, 52972–52979.
Cheng, Z. J., & Miller, L. J. (2001). Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. Journal of Biological Chemistry, 276, 48040–48047.
Cvejic, S., & Devi, L. A. (1997). Dimerization of the delta opioid receptor: Implication for a role in receptor internalization. Journal of Biological Chemistry, 272, 26959–26964.
Dawson, J. P., Berger, M. B., Lin, C. C., Schlessinger, J., Lemmon, M. A., & Ferguson, K. M. (2005). Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Molecular and Cellular Biology, 25, 7734–7742.
Ding, W. Q., Cheng, Z. J., McElhiney, J., Kuntz, S. M., & Miller, L. J. (2002). Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Research, 62, 5223–5229.
Dong, M., Lam, P. C., Gao, F., Hosohata, K., Pinon, D. I., Sexton, P. M., et al. (2007). Molecular Approximations between residues 21 and 23 of secretin and its receptor: Development of a model for peptide docking with the amino terminus of the secretin receptor. Molecular Pharmacology, 72, 280–290.
Dong, M., & Miller, L. J. (2002). Molecular pharmacology of the secretin receptor. Receptors Channels, 8, 189–200.
Hague, C., Lee, S. E., Chen, Z., Prinster, S. C., Hall, R. A., & Minneman, K. P. (2006). Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity. Molecular Pharmacology, 69, 45–55.
Harikumar, K. G., Dong, M., Cheng, Z., Pinon, D. I., Lybrand, T. P., & Miller, L. J. (2006a). Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function. Biochemistry, 45, 14706–14716.
Harikumar, K. G., Morfis, M. M., Lisenbee, C. S., Sexton, P. M., & Miller, L. J. (2006b). Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors. Molecular Pharmacology, 69, 363–373.
Harikumar, K. G., Pinon, D. I., & Miller, L. J. (2007). Transmembrane segment four contributes a functionally-important interface for oligomerization of the class II G protein-coupled secretin receptor. Journal of Biological Chemistry, 282, 30363–30372.
Lisenbee, C. S., Dong, M., & Miller, L. J. (2005). Paired cysteine mutagenesis to establish the pattern of disulfide bonds in the functional intact secretin receptor. Journal of Biological Chemistry, 280, 12330–12338.
Lisenbee, C. S., Harikumar, K. G., & Miller, L. J. (2007). Mapping the architecture of secretin receptors with intramolecular fluorescence resonance energy transfer using acousto-optic tunable filter-based spectral imaging. Molecular Endocrinology, 21, 1997–2008.
Lisenbee, C. S., & Miller, L. J. (2006). Secretin receptor oligomers form intracellularly during maturation through receptor core domains. Biochemistry, 45, 8216–8226.
Milligan, G. (2004). G protein-coupled receptor dimerization: Function and ligand pharmacology. Molecular Pharmacology, 66, 1–7.
Milligan, G. (2007). G protein-coupled receptor dimerisation: Molecular basis and relevance to function. Biochimica et Biophysica Acta, 1768, 825–835.
Park, P. S., Filipek, S., Wells, J. W., & Palczewski, K. (2004). Oligomerization of G protein-coupled receptors: Past, present, and future. Biochemistry, 43, 15643–15656.
Pascal, G., & Milligan, G. (2005). Functional complementation and the analysis of opioid receptor homodimerization. Molecular Pharmacology, 68, 905–915.
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000a). Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science, 288, 154–157.
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000b). Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. Journal of Biological Chemistry, 275, 7862–7869.
Salom, D., Lodowski, D. T., Stenkamp, R. E., Le Trong, I., Golczak, M., Jastrzebska, B., et al. (2006). Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proceedings of the National Academy of Sciences of the United States of America, 103, 16123–16128.
Seck, T., Baron, R., & Horne, W. C. (2003). The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression. Journal of Biological Chemistry, 278, 23085–23093.
Terrillon, S., & Bouvier, M. (2004). Roles of G-protein-coupled receptor dimerization. EMBO Reports, 5, 30–34.
Acknowledgments
The authors thank Ms. L.-A. Bruins for excellent technical assistance and Ms. E. Posthumus for secretarial assistance. This work was supported by grants from the National Institutes of Health, DK46577 (LJM), National Health and Medical Research Council of Australia (NHMRC) grant 436780 (PMS), and by the Fiterman Foundation (LJM). PMS is a NHMRC Principal Research Fellow.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harikumar, K.G., Morfis, M.M., Sexton, P.M. et al. Pattern of Intra-Family Hetero-Oligomerization Involving the G-Protein-Coupled Secretin Receptor. J Mol Neurosci 36, 279–285 (2008). https://doi.org/10.1007/s12031-008-9060-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9060-z